| Primary |
| Breast Cancer |
31.2% |
| Diffuse Large B-cell Lymphoma |
18.9% |
| B-cell Lymphoma |
10.8% |
| Malignant Lymphoid Neoplasm |
6.2% |
| Prophylaxis |
5.3% |
| Non-hodgkin's Lymphoma |
5.1% |
| Product Used For Unknown Indication |
3.8% |
| Hodgkin's Disease |
3.4% |
| Hypertension |
3.1% |
| Lung Neoplasm Malignant |
2.5% |
| Chemotherapy |
2.1% |
| Pain |
1.1% |
| Uterine Leiomyosarcoma |
1.1% |
| Nausea |
1.0% |
| Acute Myeloid Leukaemia |
1.0% |
| Infection |
0.7% |
| Lymphoma |
0.7% |
| Chronic Lymphocytic Leukaemia |
0.7% |
| Constipation |
0.6% |
| Febrile Neutropenia |
0.6% |
|
| Febrile Neutropenia |
27.3% |
| Pyrexia |
9.3% |
| Ejection Fraction Decreased |
6.2% |
| Pain |
4.6% |
| Pulmonary Embolism |
4.6% |
| Syncope |
4.1% |
| Vomiting |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Neutropenia |
3.6% |
| Pneumonia |
3.6% |
| Back Pain |
3.1% |
| Infection |
3.1% |
| Left Ventricular Dysfunction |
3.1% |
| Myelodysplastic Syndrome |
3.1% |
| Urinary Tract Infection |
3.1% |
| Chest Pain |
2.6% |
| Dyspnoea |
2.6% |
| Pancytopenia |
2.6% |
| Platelet Count Decreased |
2.6% |
| Thrombocytopenia |
2.6% |
|
| Secondary |
| B-cell Lymphoma |
17.9% |
| Breast Cancer |
17.4% |
| Product Used For Unknown Indication |
13.0% |
| Diffuse Large B-cell Lymphoma |
12.5% |
| Prophylaxis |
6.3% |
| T-cell Lymphoma |
5.4% |
| Chronic Lymphocytic Leukaemia |
5.0% |
| Hypertension |
3.6% |
| Sarcoma |
3.3% |
| Acute Myeloid Leukaemia |
3.0% |
| Drug Use For Unknown Indication |
1.9% |
| Neutropenia |
1.8% |
| Infection Prophylaxis |
1.7% |
| Pain |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Depression |
1.2% |
| Chemotherapy |
1.0% |
| Malignant Lymphoid Neoplasm |
1.0% |
| Diabetes Mellitus |
0.9% |
| Constipation |
0.8% |
|
| Febrile Neutropenia |
15.3% |
| Pyrexia |
8.4% |
| Vomiting |
8.4% |
| Dyspnoea |
7.0% |
| Hypertension |
6.1% |
| Pleural Effusion |
5.3% |
| Thrombocytopenia |
5.3% |
| Pulmonary Embolism |
4.7% |
| Dehydration |
4.5% |
| Urinary Tract Infection |
4.5% |
| Weight Decreased |
3.9% |
| Neutropenia |
3.6% |
| Infection |
3.3% |
| Syncope |
3.3% |
| White Blood Cell Count Decreased |
3.1% |
| Pneumonia |
2.8% |
| Skin Infection |
2.8% |
| Stomatitis |
2.8% |
| Chest Pain |
2.5% |
| Fall |
2.5% |
|
| Concomitant |
| Breast Cancer |
16.5% |
| Product Used For Unknown Indication |
12.7% |
| Drug Use For Unknown Indication |
12.4% |
| Prophylaxis |
11.3% |
| B-cell Lymphoma |
5.8% |
| Diffuse Large B-cell Lymphoma |
5.5% |
| Chronic Lymphocytic Leukaemia |
4.7% |
| Premedication |
3.6% |
| Ovarian Cancer |
3.5% |
| Nausea |
3.3% |
| Non-hodgkin's Lymphoma |
3.0% |
| Hypertension |
2.4% |
| Acute Lymphocytic Leukaemia |
2.2% |
| Non-small Cell Lung Cancer |
2.2% |
| Pain |
2.2% |
| Lymphoma |
1.9% |
| Lymphoma Aids Related |
1.8% |
| Prostate Cancer |
1.8% |
| Constipation |
1.7% |
| Mantle Cell Lymphoma |
1.7% |
|
| Vomiting |
13.7% |
| Pyrexia |
8.2% |
| Febrile Neutropenia |
7.9% |
| Pneumonia |
7.5% |
| Pancytopenia |
6.5% |
| Thrombocytopenia |
5.8% |
| Death |
5.1% |
| Sepsis |
5.1% |
| Renal Failure Acute |
4.8% |
| Urinary Tract Infection |
4.1% |
| Neutropenia |
3.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Weight Decreased |
3.4% |
| Atrial Fibrillation |
3.1% |
| Dehydration |
3.1% |
| Infection |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Vision Blurred |
3.1% |
| Bone Marrow Failure |
2.7% |
| Tachycardia |
2.4% |
|
| Interacting |
|
|
